For the Inventor, By the Inventor

Enter assignee name

Pittsburgh, PA, United States of America

Precision Therapeutics, Inc.

USPTO Granted Patents = 21

EPO Patents = 1

Trademarks = 10

Forward Citations = 427

Loading Chart...

Loading Chart...

13 inventors (with patents filed for the assignee):

Paul L Kornblith (17 out of 17 patents)

Sean McDonald (5 out of 5 patents)

Michael J Gabrin (2 out of 4 patents)

4. Stacey Brower (2 out of 2 patents)

5. Payal Nanavati (2 out of 2 patents)

6. Holly Gallion (2 out of 2 patents)

7. Shara Dawn Rice (2 out of 2 patents)

8. Anuja Chattopadhyay (2 out of 2 patents)

9. Zhibao Mi (1 out of 3 patents)

10. Dave Gingrich (1 out of 1 patent)

11. Mike Gabrin (1 out of 1 patent)

12. Sheri Gimigliano (1 out of 1 patent)

13. Michael W Zislis (1 out of 1 patent)

21 patents: Sort by Forward Citations

1. 8236489 - Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics (2012-08-07),

2. 8187800 - Methods for selecting active agents for cancer treatment (2012-05-29),

3. 8183009 - Assaying cellular markers for the evaluation of tumors (2012-05-22),

4. 8058025 - Methods for determining efficacy of chemotherapeutic agents (2011-11-15),

5. 8039213 - Methods for assessing efficacy of chemotherapeutic agents (2011-10-18),

6. 7972769 - Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays (2011-07-05),

7. 7829288 - Methods for assessing efficacy of chemotherapeutic agents (2010-11-09),

8. 7771963 - Methods for determining efficacy of chemotherapeutic agents (2010-08-10),

9. 7678552 - Method for selecting therapeutic agents for cancer treatment (2010-03-16),

10. 7642048 - Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics (2010-01-05),

11. 7575868 - Methods for assessing efficacy of chemotherapeutic agents (2009-08-18),

12. 7563593 - Method for preparing cell cultures from biological specimens for assaying secreted factors (2009-07-21),

13. 7501260 - Methods for determining efficacy of chemotherapeutic agents for a patient prior to treatment (2009-03-10),

14. 7314731 - Method for selecting therapeutic agents for cancer (2008-01-01),

15. 7112415 - Method of preparing cell cultures from biological specimens for assaying a response to an agent (2006-09-26),

Precision Therapeutics, Inc. is a leading healthcare company specializing in the development of innovative diagnostic technologies to personalize cancer care. With a focus on empowering physicians with valuable information to make optimal treatment decisions, Precision Therapeutics is dedicated to improving patient outcomes. Their cutting-edge products and services enable personalized medicine by providing individualized molecular profiles of cancer tumors, allowing for better personalized treatment plans.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

21 Patents

#94 in Pittsburgh, PA

#562 in Pennsylvania

#15,156 in US

#29,052 in the World

Pittsburgh, PA, United States of America

Precision Therapeutics, Inc.

Forward Citations = 427

13 inventors:

Paul L Kornblith (17 out of 17 patents)

Sean McDonald (5 out of 5 patents)

Michael J Gabrin (2 out of 4 patents)

4. Stacey Brower (2 out of 2 patents)

5. Payal Nanavati (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com

Loading…